Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

NCT06291883 is registered in ClinicalTrials.gov with Sheng-Teng Huang as lead sponsor.

NCT NCT06291883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.
Lead sponsor
Sheng-Teng Huang
Phase
Phase 1
Overall status
Completed
Start date
February 9, 2023
Completion date
February 8, 2024
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2 infection